Modelling anti-pertussis toxin IgG antibody decay following primary and preschool vaccination with an acellular pertussis vaccine in UK subjects using a modified oral fluid assay

Journal of Medical Microbiology

Volumn 62, Issue , 2013, Pages 1281-1289

  Fry, Norman K ^a   Litt, David J ^a   Duncan, John ^a   Vaghji, Lalita ^a   Warrener, Lenesha ^a   Samuel, Dhanraj ^a   Andrews, Nick ^a   Harnden, Anthony ^b   Harrison, Timothy G ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS POLIOMYELITIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B VACCINE; DIPHTHERIA PERTUSSIS POLIOMYELITIS TETANUS VACCINE; DIPHTHERIA PERTUSSIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B VACCINE; IMMUNOGLOBULIN G ANTIBODY; INFANRIX IPV; MONOCLONAL ANTIBODY; PERTUSSIS TOXIN IMMUNOGLOBULIN ANTIBODY; PERTUSSIS VACCINE; TOXIN ANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; BORDETELLA PERTUSSIS; CHEMICAL MODEL; CHILD; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MAJOR CLINICAL STUDY; PERTUSSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SINGLE DRUG DOSE; UNITED KINGDOM; VACCINATION;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTIBODY FORMATION; BORDETELLA PERTUSSIS; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GREAT BRITAIN; HUMANS; IMMUNIZATION SCHEDULE; IMMUNIZATION, SECONDARY; IMMUNOGLOBULIN G; INFANT; MICE; MICE, INBRED BALB C; PERTUSSIS TOXIN; PERTUSSIS VACCINE; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; TIME FACTORS; VACCINES, ACELLULAR; WHOOPING COUGH;

EID: 84881566624     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.062000-0     Document Type: Article

References (20)

1. Borrow, R., Andrews, N., Findlow, H., Waight, P., Southern, J., Crowley-Luke, A., Stapley, L., England, A., Findlow, J. & Miller, E. (2010). Kinetics of antibody persistence following administration of a combination meningococcal serogroup C and Haemophilus influenzae type b conjugate vaccine in healthy infants in the United Kingdom primed with a monovalent meningococcal serogroup C vaccine. Clin Vaccine Immunol 17, 154-159.
2. Campbell, H., Amirthalingam, G., Andrews, N., Fry, N. K., George, R. C., Harrison, T. G. & Miller, E. (2012). Accelerating control of pertussis in England and Wales. Emerg Infect Dis 18, 38-47.
3. Cherry, J. D. (1999). Epidemiological, clinical, and laboratory aspects of pertussis in adults. Clin Infect Dis 28 (Suppl 2), S112-S117.
4. Dalby, T., Petersen, J. W., Harboe, Z. B. & Krogfelt, K. A. (2010). Antibody responses to pertussis toxin display different kinetics after clinical Bordetella pertussis infection than after vaccination with an acellular pertussis vaccine. J Med Microbiol 59, 1029-1036.
5. Fry, N. K., Duncan, J., Wagner, K., Tzivra, O., Doshi, N., Litt, D. J., Crowcroft, N., Miller, E., George, R. C. & Harrison, T. G. (2009). Role of PCR in the diagnosis of pertussis infection in infants: 5 years' experience of provision of a same-day real-time PCR service in England and Wales from 2002 to 2007. J Med Microbiol 58, 1023-1029.
6. Guiso, N., Berbers, G., Fry, N. K., He, Q., Riffelmann, M., Wirsing von König, C. H. & EU Pertstrain group (2011). What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories. Eur J Clin Microbiol Infect Dis 30, 307-312.
7. Harnden, A., Grant, C., Harrison, T., Perera, R., Brueggemann, A. B., Mayon-White, R. & Mant, D. (2006). Whooping cough in school age children with persistent cough: prospective cohort study in primary care. BMJ 333, 174-177.
8. He, Q., Barkoff, A. M., Mertsola, J., Glismann, S., Bacci, S. & European Bordetella expert group (EUpertstrain) & European surveillance network for vaccine-preventable diseases (EUVAC. NET) (2012). High heterogeneity in methods used for the laboratory confirmation of pertussis diagnosis among European countries, 2010: integration of epidemiological and laboratory surveillance must include standardisation of methodologies and quality assurance. Euro Surveill 17, 20239.
9. Health Protection Agency (2007a). Health Protection Report 1, No. 25, 2-3, 22 June 2007 http://www.hpa.org.uk/hpr/archives/2007/ hpr2507.pdf
10. Health Protection Agency (2007b). Health Protection Report. 1, No. 26, 3, 29 June 2007 http://www.hpa.org.uk/hpr/archives/2007/hpr2607.pdf
11. Köhler, G. & Milstein, C. (1975). Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256, 495-497.
12. Leary, J. J., Brigati, D. J. & Ward, D. C. (1983). Rapid and sensitive colorimetric method for visualizing biotin-labeled DNA probes hybridized to DNA or RNA immobilized on nitrocellulose: Bio-blots. Proc Natl Acad Sci U S A 80, 4045-4049.
13. Litt, D. J., Samuel, D., Duncan, J., Harnden, A., George, R. C. & Harrison, T. G. (2006). Detection of anti-pertussis toxin IgG in oral fluids for use in diagnosis and surveillance of Bordetella pertussis infection in children and young adults. J Med Microbiol 55, 1223-1228.
14. Morris, M., Cohen, B., Andrews, N. & Brown, D. (2002). Stability of total and rubella-specific IgG in oral fluid samples: the effect of time and temperature. J Immunol Methods 266, 111-116.
15. Mortimer, P. P. & Parry, J. V. (1988). The use of saliva for viral diagnosis and screening. Epidemiol Infect 101, 197-201.
16. Pebody, R. G., Gay, N. J., Giammanco, A., Baron, S., Schellekens, J., Tischer, A., Ölander, R.-M., Andrews, N. J., Edmunds, W. J. & other authors (2005). The seroepidemiology of Bordetella pertussis infection in Western Europe. Epidemiol Infect 133, 159-171.
17. Sheppard, C., Cohen, B., Andrews, N. & Surridge, H. (2001). Development and evaluation of an antibody capture ELISA for detection of IgG to Epstein-Barr virus in oral fluid samples. J Virol Methods 93, 157-166.
18. Towbin, H., Staehelin, T. & Gordon, J. (1979). Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A 76, 4350-4354.
19. Watanabe, M., Connelly, B. & Weiss, A. A. (2006). Characterization of serological responses to pertussis. Clin Vaccine Immunol 13, 341-348.
20. Wilson, M. B. & Nakane, P. K. (1978). Recent developments in the periodate method of conjugating horseradish peroxidase (HRPO) to antibodies. In Immunofluorescence and Related Staining Techniques, pp. 215-224. Edited by W. Knapp, G. Wick & K. Holubar. Amsterdam: Elsevier.